# Sweetgreen, Inc.: financial statements, quarterly

SG · NYSE · CIK 1477815 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sg.md) · [Financials](/companies/sg/financials.md) · [Filings](/companies/sg/filings.md) · [Insiders](/companies/sg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [153](/filings/0001628280-24-046463.md) | [153 d](/filings/0001628280-26-012520.md) | [158](/filings/0001628280-25-023817.md) | [185](/filings/0001628280-25-039058.md) | [173](/filings/0001628280-25-050385.md) | [161 d](/filings/0001628280-26-012520.md) | [166](/filings/0001628280-26-032481.md) | [186](/filings/0001628280-26-054522.md) | [172](/filings/0001628280-25-050385.md) | [155 d](/filings/0001628280-26-012520.md) | [162](/filings/0001628280-26-032481.md) | [193](/filings/0001628280-26-054522.md) |
| Research and development | $m | [0.4](/filings/0001628280-24-046463.md) | [0.3 d](/filings/0001628280-25-008367.md) | [0.3](/filings/0001628280-24-022413.md) | [0.3](/filings/0001628280-24-036302.md) | [0.3](/filings/0001628280-24-046463.md) | [0.3 d](/filings/0001628280-26-012520.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(26.5)](/filings/0001628280-24-046463.md) | [(29.3) d](/filings/0001628280-26-012520.md) | [(26.9)](/filings/0001628280-25-023817.md) | [(16.2)](/filings/0001628280-25-039058.md) | [(21.2)](/filings/0001628280-25-050385.md) | [(31.4) d](/filings/0001628280-26-012520.md) | [(28.5)](/filings/0001628280-26-032481.md) | [(26.4)](/filings/0001628280-26-054522.md) | [(36.3)](/filings/0001628280-25-050385.md) | [(48.1) d](/filings/0001628280-26-012520.md) | [(34.3)](/filings/0001628280-26-032481.md) | [(27.4)](/filings/0001628280-26-054522.md) |
| Interest expense | $m | [0.0](/filings/0001628280-24-046463.md) | [0.1 d](/filings/0001628280-26-012520.md) | [0.0](/filings/0001628280-25-023817.md) | [0.2](/filings/0001628280-25-039058.md) | [0.0](/filings/0001628280-25-050385.md) | [0.0 d](/filings/0001628280-26-012520.md) | [0.0](/filings/0001628280-26-032481.md) | [0.0](/filings/0001628280-26-054522.md) | [0.0](/filings/0001628280-25-050385.md) | [0.0 d](/filings/0001628280-26-012520.md) | [0.0](/filings/0001628280-26-032481.md) | [0.1](/filings/0001628280-26-054522.md) |
| Income tax | $m | [0.3](/filings/0001628280-24-046463.md) | [(0.6) d](/filings/0001628280-26-012520.md) | [0.1](/filings/0001628280-25-023817.md) | [0.1](/filings/0001628280-25-039058.md) | [0.1](/filings/0001628280-25-050385.md) | [(1.6) d](/filings/0001628280-26-012520.md) | [0.1](/filings/0001628280-26-032481.md) | [0.1](/filings/0001628280-26-054522.md) | [0.1](/filings/0001628280-25-050385.md) | [(0.3) d](/filings/0001628280-26-012520.md) | [1.8](/filings/0001628280-26-032481.md) | [0.0](/filings/0001628280-26-054522.md) |
| Net income | $m | [(25.1)](/filings/0001628280-24-046463.md) | [(27.4) d](/filings/0001628280-26-012520.md) | [(26.1)](/filings/0001628280-25-023817.md) | [(14.5)](/filings/0001628280-25-039058.md) | [(20.8)](/filings/0001628280-25-050385.md) | [(29.0) d](/filings/0001628280-26-012520.md) | [(25.0)](/filings/0001628280-26-032481.md) | [(23.2)](/filings/0001628280-26-054522.md) | [(36.1)](/filings/0001628280-25-050385.md) | [(49.7) d](/filings/0001628280-26-012520.md) | [126](/filings/0001628280-26-032481.md) | [(26.3)](/filings/0001628280-26-054522.md) |
| Diluted EPS | $ per share | [(0.22)](/filings/0001628280-24-046463.md) | not reported | [(0.23)](/filings/0001628280-25-023817.md) | [(0.13)](/filings/0001628280-25-039058.md) | [(0.18)](/filings/0001628280-25-050385.md) | not reported | [(0.21)](/filings/0001628280-26-032481.md) | [(0.20)](/filings/0001628280-26-054522.md) | [(0.31)](/filings/0001628280-25-050385.md) | not reported | [1.05](/filings/0001628280-26-032481.md) | [(0.22)](/filings/0001628280-26-054522.md) |
| Basic EPS | $ per share | [(0.22)](/filings/0001628280-24-046463.md) | not reported | [(0.23)](/filings/0001628280-25-023817.md) | [(0.13)](/filings/0001628280-25-039058.md) | [(0.18)](/filings/0001628280-25-050385.md) | not reported | [(0.21)](/filings/0001628280-26-032481.md) | [(0.20)](/filings/0001628280-26-054522.md) | [(0.31)](/filings/0001628280-25-050385.md) | not reported | [1.06](/filings/0001628280-26-032481.md) | [(0.22)](/filings/0001628280-26-054522.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-24) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [275](/filings/0001628280-23-036508.md) | [257](/filings/0001628280-25-008367.md) | [244](/filings/0001628280-24-022413.md) | [245](/filings/0001628280-24-036302.md) | [235](/filings/0001628280-24-046463.md) | [215](/filings/0001628280-26-012520.md) | [184](/filings/0001628280-25-023817.md) | [168](/filings/0001628280-25-039058.md) | [130](/filings/0001628280-25-050385.md) | [89.2](/filings/0001628280-26-054522.md) | [157](/filings/0001628280-26-032481.md) | [143](/filings/0001628280-26-054522.md) |
| Current assets | $m | [299](/filings/0001628280-23-036508.md) | [276](/filings/0001628280-25-008367.md) | [264](/filings/0001628280-24-022413.md) | [266](/filings/0001628280-24-036302.md) | [255](/filings/0001628280-24-046463.md) | [235](/filings/0001628280-26-012520.md) | [206](/filings/0001628280-25-023817.md) | [190](/filings/0001628280-25-039058.md) | [150](/filings/0001628280-25-050385.md) | [130](/filings/0001628280-26-054522.md) | [175](/filings/0001628280-26-032481.md) | [164](/filings/0001628280-26-054522.md) |
| Total assets | $m | [880](/filings/0001628280-23-036508.md) | [857](/filings/0001628280-25-008367.md) | [843](/filings/0001628280-24-022413.md) | [859](/filings/0001628280-24-036302.md) | [858](/filings/0001628280-24-046463.md) | [857](/filings/0001628280-26-012520.md) | [834](/filings/0001628280-25-023817.md) | [832](/filings/0001628280-25-039058.md) | [825](/filings/0001628280-25-050385.md) | [788](/filings/0001628280-26-054522.md) | [913](/filings/0001628280-26-032481.md) | [896](/filings/0001628280-26-054522.md) |
| Current liabilities | $m | [81.1](/filings/0001628280-23-036508.md) | [91.6](/filings/0001628280-25-008367.md) | [87.3](/filings/0001628280-24-022413.md) | [97.6](/filings/0001628280-24-036302.md) | [98.5](/filings/0001628280-24-046463.md) | [116](/filings/0001628280-26-012520.md) | [105](/filings/0001628280-25-023817.md) | [104](/filings/0001628280-25-039058.md) | [116](/filings/0001628280-25-050385.md) | [119](/filings/0001628280-26-054522.md) | [109](/filings/0001628280-26-032481.md) | [114](/filings/0001628280-26-054522.md) |
| Total liabilities | $m | [380](/filings/0001628280-23-036508.md) | [374](/filings/0001628280-25-008367.md) | [372](/filings/0001628280-24-022413.md) | [389](/filings/0001628280-24-036302.md) | [395](/filings/0001628280-24-046463.md) | [411](/filings/0001628280-26-012520.md) | [402](/filings/0001628280-25-023817.md) | [409](/filings/0001628280-25-039058.md) | [431](/filings/0001628280-25-050385.md) | [432](/filings/0001628280-26-054522.md) | [424](/filings/0001628280-26-032481.md) | [428](/filings/0001628280-26-054522.md) |
| Shareholders' equity | $m | [500](/filings/0001628280-24-046463.md) | [483](/filings/0001628280-26-012520.md) | [470](/filings/0001628280-25-039058.md) | [470](/filings/0001628280-25-050385.md) | [463](/filings/0001628280-25-050385.md) | [446](/filings/0001628280-26-054522.md) | [433](/filings/0001628280-26-054522.md) | [423](/filings/0001628280-26-054522.md) | [393](/filings/0001628280-25-050385.md) | [356](/filings/0001628280-26-054522.md) | [489](/filings/0001628280-26-054522.md) | [468](/filings/0001628280-26-054522.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.7 d](/filings/0001628280-24-046463.md) | [8.9 d](/filings/0001628280-26-012520.md) | [3.4](/filings/0001628280-25-023817.md) | [19.1 d](/filings/0001628280-25-039058.md) | [14.7 d](/filings/0001628280-25-050385.md) | [6.1 d](/filings/0001628280-26-012520.md) | [(13.1)](/filings/0001628280-26-032481.md) | [10.5 d](/filings/0001628280-26-054522.md) | [(1.4) d](/filings/0001628280-25-050385.md) | [(8.7) d](/filings/0001628280-26-012520.md) | [(17.2)](/filings/0001628280-26-032481.md) | [(0.4) d](/filings/0001628280-26-054522.md) |
| Capital expenditure | $m | [19.1 d](/filings/0001628280-24-046463.md) | [14.8 d](/filings/0001628280-26-012520.md) | [13.4](/filings/0001628280-25-023817.md) | [19.3 d](/filings/0001628280-25-039058.md) | [25.1 d](/filings/0001628280-25-050385.md) | [26.7 d](/filings/0001628280-26-012520.md) | [16.7](/filings/0001628280-26-032481.md) | [23.6 d](/filings/0001628280-26-054522.md) | [35.8 d](/filings/0001628280-25-050385.md) | [30.3 d](/filings/0001628280-26-012520.md) | [12.4](/filings/0001628280-26-032481.md) | [10.1 d](/filings/0001628280-26-054522.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [110](/filings/0001628280-23-036508.md) | [111](/filings/0001628280-24-022413.md) | [112](/filings/0001628280-24-036302.md) | [112](/filings/0001628280-24-046463.md) | [113](/filings/0001628280-25-023817.md) | [114](/filings/0001628280-25-039058.md) | [115](/filings/0001628280-25-050385.md) | [117](/filings/0001628280-26-032481.md) | [118](/filings/0001628280-26-054522.md) | [118](/filings/0001628280-25-050385.md) | [120](/filings/0001628280-26-032481.md) | [119](/filings/0001628280-26-054522.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 96,076,681 at 2022-05-03, from the cover of the [10-Q filed 2022-05-06](/filings/0001628280-22-013042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.